Many AI deployments miss ROI because expectations outpace reality: probabilistic tools, shifting behavior, weak economics, ...
A new technique from Stanford, Nvidia, and Together AI lets models learn during inference rather than relying on static ...
The Chosun Ilbo (English Edition) on MSN

AlphaGenome decodes 98% genome, identifies disease causes

Google DeepMind’s research team recently published in the international academic journal *Nature* the development process of ...
Rather than use AI to achieve scientific breakthroughs, Anthropic is betting AI agents can make the routine work of science ...
Discover how researchers are overcoming the limitations of the undruggable target in drug discovery using novel approaches ...
How Isomorphic Labs Is Rewriting Drug Discovery. Google DeepMind spin-off Isomorphic Labs is building an AI drug design engine that it believes can“solve” all diseases. We spoke to its Chief Technolog ...
Google DeepMind, the artificial intelligence subsidiary of Alphabet, has made another leap in its efforts to illuminate human ...
The American Heart Association released its 2026 Heart Disease and Stroke Statistics Update, and a reminder that heart ...
Pick two.” But a team from the University of Virginia School of Medicine has discovered a way to make vaccines that embrace ...
AI Impact examines responsible AI, creative scale, deployment friction and the leaders steering AI adoption.
Google DeepMind released AlphaGenome on January 28, an AI model that predicts how DNA sequences translate into biological functions, processing up to one million base-pairs at once and outperforming ...